FR181157 structure
|
Common Name | FR181157 | ||
|---|---|---|---|---|
| CAS Number | 171046-15-4 | Molecular Weight | 487.52 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C30H26NNaO4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of FR181157FR181157, an orally active PGI2 agonist activity with especially good pharmacokinetic properties[1]. |
| Name | sodium,2-[3-[[(1S)-2-(4,5-diphenyl-1,3-oxazol-2-yl)cyclohex-2-en-1-yl]methyl]phenoxy]acetate |
|---|---|
| Synonym | More Synonyms |
| Description | FR181157, an orally active PGI2 agonist activity with especially good pharmacokinetic properties[1]. |
|---|---|
| Related Catalog | |
| In Vitro | FR181157 exhibits high binding affinity for the IP receptor with a Ki of 54 nM and anti-aggregative potency with an IC50 of 60 nM[1]. |
| References |
| Molecular Formula | C30H26NNaO4 |
|---|---|
| Molecular Weight | 487.52 |
| Exact Mass | 487.17600 |
| PSA | 75.39000 |
| LogP | 5.56350 |
| Acetic acid,(3-((2-(4,5-diphenyl-2-oxazolyl)-2-cyclohexen-1-yl)methyl)phenoxy)-,sodium salt,(S) |
| Acetic acid,(3-(((1S)-2-(4,5-diphenyl-2-oxazolyl)-2-cyclohexen-1-yl)methyl)phenoxy)-,sodium salt |